London, Oct. 30, 2019 (GLOBE NEWSWIRE) -- According to a new market research report, In-Vitro Toxicology/Toxicity Testing Market by Product& Service, Technology (Cell Culture, OMICS), Method (Cell-based Assays, In-Silico), End-point (ADME, Genotoxicity, Organ Toxicity, Dermal Toxicity), End-user, and Geography – Global Forecast to 2025”, published by Meticulous Research®, the global in-vitro toxicology testing market is expected to grow at a CAGR of 9% from 2019 to reach $14.4 billion by 2025.
The growth in the overall in-vitro toxicology testing market is driven by factors, such as ethical issues and pressure from animal activists’ groups concerning the use of animals for testing, ban on animal testing on cosmetic products, support from regulatory bodies regarding the approval of in vitro tests, low costs associated with in-vitro toxicology testing, and advancements in in-vitro methodologies. Moreover, synergetic relationships between various stakeholders in the industry and increasing toxicology databases to facilitate the use of in vitro test methods are expected to offer significant growth opportunities for the players operating in this market.
Request Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=5047
The global in-vitro toxicology testing market is mainly segmented by product & service (equipment, assay kits, consumables, software, services), technology (cell culture technologies, high-throughput screening technologies, OMICS technologies), method (cell-based assays, biochemical assays, in-silico, ex-vivo), end-point (ADME; skin irritation, corrosion, sensitization; genotoxicity; cytotoxicity; ocular toxicity; organ toxicity; phototoxicity; and dermal toxicity), and end-user (pharmaceutical & biotechnology industries, cosmetics industry, food industry, and chemical industry). The study also evaluates industry competitors and analyzes the market at a regional and country level.
The consumables segment is estimated to dominate the global in vitro toxicology testing market in 2019, mainly due to increasing number of in vitro tests being performed across the globe leading to recurrent purchase of reagents and other labware. However, the software segment is projected to grow at the fastest CAGR during the forecast period. The growth of this segment can be attributed to increasing computer models and algorithms being developed to predict toxicity of test substances.
On the basis of technology, the cell culture technologies segment is estimated to account for the largest share of the in vitro toxicology testing market in 2019, owing to growing adoption of 3D cell culture and stem cell models.
Meticulous Research® is Glad to Announce Year-End Discount Offer.
Grab Maximum 25% Discount On All Our Research Reports, Discount Valid Till 31st December 2019
On the basis of method, the cell-based assays segment is estimated to account for the largest share of the overall in-vitro toxicology testing market in 2019. Advancements in cell-based technologies such as high-content screening and label-free detection are expected to further drive the market growth for cell-based assays.
Geographically, Europe commanded the largest share of global in vitro toxicology testing, followed by North America and Asia Pacific (APAC). The large share of this region is mainly attributed to the factors such as ban on animal testing for cosmetics and its ingredients and government initiatives to promote the reduction of use of animals for toxicity testing. On the other hand, Asia-Pacific region is expected to grow at the highest CAGR for next 5-6 years, owing to increasing biotech investments in this region and growing collaborations between local and foreign companies.
The overall in vitro toxicology testing market is a highly consolidated in nature, wherein top 3 major players — Thermo Fisher Scientific (US), Merck (Germany), and GE Healthcare (US) - accounted for a major share of the global in vitro toxicity testing market. Other key players operating in this market are Bio-Rad Laboratories (US), SGS SA (Switzerland), Laboratory Corporation of America Holdings (U.S.), Qiagen N.V. (Netherlands), and Eurofins Scientific (Luxembourg), among others.
Browse key industry insights spread across 189 pages with 120 market data tables & 30 figures & charts from the report: https://www.meticulousresearch.com/product/in-vitro-toxicology-toxicity-testing-market-5047/
Scope of the Report:
In-Vitro Toxicology/Toxicity Testing Market by Product & Service
- Equipment
- Assay Kits
- Consumables
- Software
- Services
In-Vitro Toxicology/Toxicity Testing Market by Technology
- Cell Culture Technologies
- High-Throughput Screening Technologies
- OMICS Technologies
In-Vitro Toxicology/Toxicity Testing Market by Method
- Cell-based Assays
- Biochemical Assays
- In-Silico
- Ex-Vivo
In-Vitro Toxicology/Toxicity Testing Market by End-point
- ADME
- Skin Irritation, Corrosion, Sensitization
- Genotoxicity
- Cytotoxicity
- Ocular Toxicity
- Organ Toxicity
- Phototoxicity
- Dermal Toxicity
- Other Toxicity End-points
In-Vitro Toxicology/Toxicity Testing Market by End-user
- Pharmaceutical & Biotechnology Industries
- Cosmetics Industry
- Food Industry
- Chemical Industry
In-Vitro Toxicology/Toxicity Testing Market by Geography
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
- North America
- U.S.
- Canada
- Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of APAC (RoAPAC)
- Rest of World
- Latin America
- Middle East and Africa
Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5047
Related Reports:
In Vitro Diagnostics Market | IVD Market by Product (Reagent, Instruments, Software, Service), Technique [Immunoassay, Clinical Chemistry (Lipids, Renal, Thyroid), PCR], Application (Hematology, Diabetes, Nephrology, Oncology), End User (Hospital, POC) - Global Forecast to 2024
Research Report: https://www.meticulousresearch.com/product/ivd-market/
The global In Vitro Diagnostics Market is expected to grow at a CAGR of 5.7% from 2018 to reach $87.21 billion by 2024. IVDs allow healthcare providers to efficiently and accurately diagnose, monitor, screen, and assess predispositions to diseases. Owing to rising geriatric population & subsequent growth in the prevalence of chronic and infectious diseases, increasing adoption of fully automated instruments by diagnostic laboratories, and growing adoption of personalized medicine & point-of-care testing- this industry has witnessed a steady growth. Further, development of condition-specific markers and tests and growing demand for IVD products in emerging countries provides significant opportunities for the various stakeholders in this In vitro diagnostics market.
Infectious Disease Diagnostics Market by Product (Assays and Kits, Instruments, and Software and Services), Technology (Immunodiagnostics, NGS, PCR), Disease Type (Hepatitis, HIV, HPV, Tuberculosis), End User, and Geography - Global Forecast to 2025
Research Report: https://www.meticulousresearch.com/product/infectious-disease-diagnostics-market-4976/
The global infectious disease diagnostics market is expected to grow at a CAGR of 5.9% from 2018 to 2025 to reach $12.88 billion by 2025. Infectious disease diagnostic procedures are designed to diagnose and investigate the causative agent of an infectious disease. The diagnosis of the infectious diseases is majorly based on clinical presentation or more rigorous diagnostic tests. Increasing global prevalence of infectious diseases, growing awareness for early detection using specific diagnostic tests, growth in funding for research on infectious disease diagnostics, and shift in focus from centralized laboratories to decentralized point-of-care testing are the major factors driving the growth of the infectious disease diagnostics market.
About Meticulous Research®
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details.
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.
With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.